Biotech Firm Begins Human Trial Of Lassa Fever Vaccine In West Africa
A biotechnology company, INOVIO, on Wednesday, launched the phase 1B clinical trial of its Lassa vaccine as a…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.